Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Murase

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Breast Cancer (Tokyo, Japan)|September 4, 2013
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese womenYoshimasa Miyagawa, Tomohiro Miyake, Ayako Yanai, et al.
World Journal of Surgical Oncology|February 14, 2018
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypesMichiko Imamura, Takashi Morimoto, Takashi Nomura, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapyMasayuki Nagahashi, Eri Ishikawa, Takahiro Nagai, et al.
Breast Cancer (Tokyo, Japan)|February 24, 2012
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancersKeiko Murase, Ayako Yanai, Masaru Saito, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Breast Cancer (Tokyo, Japan)|September 4, 2013
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese womenYoshimasa Miyagawa, Tomohiro Miyake, Ayako Yanai, et al.
World Journal of Surgical Oncology|February 14, 2018
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypesMichiko Imamura, Takashi Morimoto, Takashi Nomura, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapyMasayuki Nagahashi, Eri Ishikawa, Takahiro Nagai, et al.
Breast Cancer (Tokyo, Japan)|February 24, 2012
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancersKeiko Murase, Ayako Yanai, Masaru Saito, et al.
Pageof 3